Information Journal Paper
APA:
Copy. (2018). Use of the new oral disease-modifying therapies for multiple sclerosis in British Columbia, Canada: The first five-years. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 25(-), 57-60. SID. https://sid.ir/paper/758510/en
Vancouver:
Copy. Use of the new oral disease-modifying therapies for multiple sclerosis in British Columbia, Canada: The first five-years. MULTIPLE SCLEROSIS AND RELATED DISORDERS[Internet]. 2018;25(-):57-60. Available from: https://sid.ir/paper/758510/en
IEEE:
Copy, “Use of the new oral disease-modifying therapies for multiple sclerosis in British Columbia, Canada: The first five-years,” MULTIPLE SCLEROSIS AND RELATED DISORDERS, vol. 25, no. -, pp. 57–60, 2018, [Online]. Available: https://sid.ir/paper/758510/en